Latest News in the pharma Industry

Research & Development

Type 2 diabetes drugs may be a valuable resource in the treatment of Alzheimer’s disease

Type 2 diabetes drugs may be a valuable resource in the treatment of Alzheimer’s disease

1 Dec 2016

T2DM therapies are capable of modifying the activity of insulin in the brain.

Read more 
Optibrium and MolPort collaborate to improve speed and cost-efficiency of drug discovery

Optibrium and MolPort collaborate to improve speed and cost-efficiency of drug discovery

30 Nov 2016

Partnership combines MolPort’s 6.3 Million HTS Compounds with StarDrop’s data analysis and compound design capabilities.

Read more 
FDA accepts BLA for avelumab for the treatment of metastatic MCC for Priority Review

FDA accepts BLA for avelumab for the treatment of metastatic MCC for Priority Review

29 Nov 2016

If approved by the FDA, avelumab could be the first treatment indicated for patients with metastatic Merkel cell carcinoma.

Read more 
Study confirms Sandoz biosimilar etanercept has equivalent efficacy to originator

Study confirms Sandoz biosimilar etanercept has equivalent efficacy to originator

27 Nov 2016

No clinically meaningful differences between biosimilar etanercept and the originator product in safety and efficacy over 52 weeks.

Read more 
European Commission approves BMS's Opdivo for Hodgkin's

European Commission approves BMS's Opdivo for Hodgkin's

24 Nov 2016

Opdivo is now the first and only PD-1 inhibitor approved for a hematologic malignancy in the European Union.

Read more 
Hopes dashed for new Alzheimer drug

Hopes dashed for new Alzheimer drug

23 Nov 2016

Lilly's solanezumab fails to meet primary endpoint of Phase III study.

Read more 
Allergan boosts its CNS pipeline with acquisition

Allergan boosts its CNS pipeline with acquisition

23 Nov 2016

Chase acquisition adds a new Phase III ready program for Alzheimer's disease to Allergan portfolio.

Read more 
New asthma treatments on the horizon?

New asthma treatments on the horizon?

22 Nov 2016

Studies suggest calcilytics may represent effective future asthma therapeutics.

Read more 
Oxford Genetics receives grant to create virus packaging cell lines

Oxford Genetics receives grant to create virus packaging cell lines

21 Nov 2016

Grant will be used to tackle one of the biggest bioproduction problems currently facing the industry

Read more 
Novartis acquires Selexys Pharmaceuticals and SelG1 antibody for reduction of pain crises in SCD

Novartis acquires Selexys Pharmaceuticals and SelG1 antibody for reduction of pain crises in SCD

21 Nov 2016

Deal followed results of Phase II SUSTAIN study of SelG1 in reduction of vaso-occlusive pain crises, a major complication of SCD with limited treatment options.

Read more 
Intarcia's NDA tackles glycemic control and poor patient adherence head on

Intarcia's NDA tackles glycemic control and poor patient adherence head on

21 Nov 2016

ITCA 650 is the first investigational drug to use Intarcia's disruptive Medici Drug Delivery System to deliver chronic medicines just once or twice yearly.

Read more 
Amgen's erenumab significantly reduces monthly migraine days in patients with episodic migraine

Amgen's erenumab significantly reduces monthly migraine days in patients with episodic migraine

20 Nov 2016

Second Phase III study confirms results from previous studies.

Read more